Dr Litleaungdej is a Thai Board-certified haematologist who serves as a pioneering specialist at Huahin Hospital. She graduated with second-class honours from Naresuan University before completing a senior fellowship at Thammasat University.

• Specialises in managing chemotherapy for blood-based cancers and disorders
• Completed advanced haematology fellowship at Thammasat University Hospital
• Co-authored a clinical risk prediction model for cancer-associated venous thromboembolism
• Member of the Pharmacy and Therapeutics Committee for clinical safety
• Expertise in ambulatory medicine and emergency medical protocols

The doctor specializes in Pediatric Hematology and Oncology, focusing on the diagnosis and treatment of blood disorders and cancers in children. With extensive experience in managing complex pediatric cases, the doctor is dedicated to advancing treatment protocols and improving patient outcomes. The doctor has contributed to numerous clinical trials and research studies, aiming to innovate pediatric oncology therapies. Accredited by leading medical boards, the doctor is committed to providing compassionate and comprehensive care to young patients and their families.

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Associate Professor Yusuf Acikgoz brings high-level expertise from The Ohio State University to Lokman Hekim University Ankara Hospital, where he has performed over 900 treatments.

• Holds specialist qualifications in both Internal Medicine and Medical Oncology
• Served as an investigator for major Phase III clinical trials including CheckMate-649
• Member of the American Society of Clinical Oncology (ASCO)
• Completed advanced immuno-oncology training through the Central European Cooperative Oncology Group in Vienna
• Awarded ECFMG and CITI certifications for high-standard clinical practice and research

Professor Cemil Bilir is a highly regarded medical oncologist who has performed over 900 procedures and holds a PhD in inorganic chemistry.

• Completed a research fellowship at Northeastern University in Boston specialising in nanomedicine
• Served as a Professor of Medical Oncology at Sakarya University Faculty of Medicine
• Personally evaluates all patient materials to create personalised chemotherapy programmes
• Active member of the American Society of Clinical Oncology (ASCO) and ESMO

Professor Hasan Atilla Ozkan is the current President of the Turkish Society of Therapeutic Apheresis and a leading expert in haematological oncology.

• Holds specialist certifications in autologous and allogeneic stem cell transplantation
• Professor at Yeditepe University Faculty of Medicine – one of Turkey's top medical schools
• Completed an EBMT stem cell transplantation course for international clinical standards
• Awarded the Young Researcher Award at the 6th Turkish Therapeutic Apheresis Congress
• Active member of the European Bone Marrow Transplantation network (EBMT)

Associate Professor Tarik Salman brings high-level expertise from top international institutions, including research and clinical roles at Moffitt Cancer Center and Memorial Sloan Kettering Cancer Center in the USA.

• Specialises in comprehensive genomic profiling to create individualised treatment plans
• Uses targeted therapies and immunotherapy alongside standard chemotherapy protocols
• Active board member of the Geriatric Oncology Association and Mediterranean Oncology Association
• Member of the American Society of Clinical Oncology since 2008
• Expert in managing rare cancers and clinical research cases

Professor Mustafa Serkan Alemdar is a dual-specialised medical oncologist and internal medicine expert at the JCI-accredited Medical Park Antalya Hospital Complex.

• Specialised in medical oncology at Akdeniz University Faculty of Medicine
• Managed complex cases at Antalya Training and Research Hospital
• Treats a wide range of solid tumours with personalised chemotherapy protocols
• Focuses on evidence-based medicine within a multidisciplinary oncology team
• Experienced in balancing high-intensity treatments with patient symptom management

Professor Irfan Cicin is a senior medical oncologist who leads complex chemotherapy programmes at İstinye University Liv Hospital Topkapı.

• Held the rank of Professor of Medical Oncology at Trakya University Faculty of Medicine since 2015
• Trained at Istanbul University Cerrahpaşa – one of Turkey's most prestigious medical institutions
• Specialises in designing personalised internal medicine protocols for diverse tumour types
• Served as Associate Professor for five years training the next generation of cancer specialists

Associate Professor Nail Paksoy is a highly active researcher in chemotherapy, serving as a sub-investigator for major trials with ROCHE, Pfizer, and AstraZeneca.

• Holds European Board Certification in Medical Oncology (ESMO), a gold standard in cancer care
• Specialises in managing chemotherapy-induced complications like thrombocytopenia
• Expert in carboplatin desensitisation protocols for patients with ovarian carcinoma
• Focuses on advanced treatments for lung, breast, and gastrointestinal cancers
• Published extensive real-world data on chemotherapy effectiveness for rare sarcomas

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acibadem District Hospital with a strong focus on managing solid tumours through chemotherapy and immunotherapy.

• Specialises in treating lung, breast, colorectal, and gastric cancers
• Expertise in geriatric oncology, tailoring treatment for older patients
• Published over 50 scientific articles on cancer prognosis and nutrition
• Serves on the editorial board for the international BMC Cancer journal
• Member of the European Society for Medical Oncology (ESMO)